Search results for

The North is expected to test another ballistic missile in the next few days. Its rhetoric has been hot in recent weeks. But there's a case to be made that once the U.S. and South Korea wrap up military exercises, the North will declare it won this war of words.

Host Michel Martin continues her interview with Senator Rand Paul. She asks whether his actions really line up with his libertarian philosophies.

In the United States, an orphan disease is one that affects fewer than 200,000 patients. These conditions often involve chronic pain or fatigue, and can be controversial and difficult to diagnose. Yet they affect around 30 million Americans. Author Laurie Edwards is one such patient.

The part of President Obama's fiscal 2014 budget plan getting the most attention is his proposal to change the way the government calculates inflation for Social Security beneficiaries. Economists call it chained CPI; some politicians call it fodder for the midterm elections.

In many parts of the South, more than one-third of seniors are taking drugs that they should avoid, an analysis of Medicare data finds. Ten percent are taking two or more potentially problematic medicines.

Legislation introduced in several states would require anyone who records evidence of animal abuse to turn it over to authorities within a set period of time. But animal rights activists aren't welcoming these measures: They see the bills as veiled attempts to stifle long-term undercover investigations that can prove a pattern of abuse.

Television networks are up in arms. The new company Aereo is charging a monthly fee to provide a high-definition feed of the basic over-the-air channels, and the stations aren't seeing a penny of it. But CEO Chet Kanojia thinks he's figured out a legal loophole.

Over the past few years, incomes in Brazil rose and unemployment plunged to record lows. But now — as the country prepares to host the World Cup and the Olympics — the numbers are changing. Growth is slowing and inflation is creeping up. Tourists and Brazilians alike are feeling the pinch.

The Indianapolis-based pharmaceutical company announced on Thursday that about 1,000 sales representatives will lose their jobs. The Wall Street Journal reports the company made the move to cut costs so it can better compete with generic drug makers.

While condemning North Korea's recent rhetoric as "unacceptable," the secretary of state also said the U.S. wants to talk — if the North is serious about discussing denuclearization.